- S‑phase kinase‑associated protein 1 (SKP1) is a highly conserved adaptor protein that plays a central role in the regulation of protein degradation through the ubiquitin–proteasome system. It is best known as a core component of the SCF complex, a major E3 ubiquitin ligase that governs key transitions in the eukaryotic cell cycle. SKP1 acts as a molecular bridge, linking Cullin‑1 to a diverse family of F‑box proteins, each of which recognises specific phosphorylated substrates. Through this modular architecture, SKP1 enables the SCF complex to target a wide range of regulatory proteins for ubiquitination, ensuring that cell‑cycle progression is timely, irreversible, and tightly controlled.
- Structurally, SKP1 is a small, stable protein that binds directly to the F‑box domain of F‑box proteins. This interaction is essential for assembling functional SCF complexes. Without SKP1, F‑box proteins cannot attach to the Cullin‑1 scaffold, and substrate recognition fails. Because each F‑box protein has unique substrate‑binding domains, SKP1 indirectly determines which proteins are selected for degradation. This makes SKP1 a central coordinator of proteolysis, integrating phosphorylation signals with ubiquitin‑mediated turnover. The ability of SKP1 to bind numerous F‑box proteins gives the SCF complex remarkable versatility, allowing it to regulate processes ranging from cell‑cycle control to signal transduction and developmental pathways.
- SKP1 is particularly important during the G₁–S transition, where it helps regulate proteins that determine whether a cell commits to DNA replication. One of the most well‑studied examples is the degradation of p27^Kip1, a cyclin‑dependent kinase inhibitor that restrains CDK activity. When p27 is phosphorylated, SKP1 recruits the F‑box protein Skp2, forming the SCF^Skp2 complex, which ubiquitinates p27 and targets it for proteasomal degradation. This removal of p27 allows cyclin E–CDK2 and cyclin A–CDK2 complexes to become fully active, driving the cell into S phase. SKP1 therefore plays a decisive role in promoting cell‑cycle progression by enabling the destruction of inhibitory proteins.
- Beyond cell‑cycle regulation, SKP1 participates in numerous other cellular pathways. It contributes to DNA‑damage responses by facilitating the turnover of proteins involved in repair and checkpoint activation. It also influences signalling pathways such as Wnt, NF‑κB, and hormone‑responsive cascades, reflecting the broad substrate specificity of SCF complexes. SKP1 is expressed in virtually all eukaryotic cells and is essential for viability, underscoring its fundamental role in maintaining protein homeostasis. Its evolutionary conservation highlights the importance of ubiquitin‑mediated degradation as a universal regulatory mechanism.
- Dysregulation of SKP1 or its associated F‑box proteins can have serious consequences for human health. Overexpression of Skp2, for example, leads to excessive degradation of p27 and contributes to uncontrolled cell proliferation, a hallmark of many cancers. Mutations that impair SKP1–F‑box interactions can disrupt substrate recognition, resulting in the accumulation of proteins that should be degraded. Because SKP1 is central to cell‑cycle control, it is increasingly recognised as a potential therapeutic target. Strategies aimed at modulating SCF activity, inhibiting Skp2, or stabilising key substrates are being explored in cancer research.
- In summary, SKP1 is an essential adaptor protein that enables the SCF complex to recognise and degrade specific regulatory proteins. By linking Cullin‑1 to F‑box proteins, SKP1 ensures that ubiquitin‑mediated proteolysis is precise, efficient, and responsive to cellular signals. Its role in controlling the G₁–S transition, maintaining protein homeostasis, and integrating signalling pathways makes it a key guardian of cell‑cycle fidelity and genomic stability.
